KARADENİZ, H. Et Al. 2020. Tofacitinib for the treatment for colchicine-resistant familial Mediterranean fever: case-based review. RHEUMATOLOGY INTERNATIONAL , vol.40, no.1 , 169-173.

KARADENİZ, H., AVANOĞLU GÜLER, A., Atas, N., SATIŞ, H., Salman, R. B., Babaoglu, H., ... TUFAN, A.(2020). Tofacitinib for the treatment for colchicine-resistant familial Mediterranean fever: case-based review. RHEUMATOLOGY INTERNATIONAL , vol.40, no.1, 169-173.

KARADENİZ, HAZAN Et Al. "Tofacitinib for the treatment for colchicine-resistant familial Mediterranean fever: case-based review," RHEUMATOLOGY INTERNATIONAL , vol.40, no.1, 169-173, 2020

KARADENİZ, HAZAN Et Al. "Tofacitinib for the treatment for colchicine-resistant familial Mediterranean fever: case-based review." RHEUMATOLOGY INTERNATIONAL , vol.40, no.1, pp.169-173, 2020

KARADENİZ, H. Et Al. (2020) . "Tofacitinib for the treatment for colchicine-resistant familial Mediterranean fever: case-based review." RHEUMATOLOGY INTERNATIONAL , vol.40, no.1, pp.169-173.

@article{article, author={HAZAN KARADENİZ Et Al. }, title={Tofacitinib for the treatment for colchicine-resistant familial Mediterranean fever: case-based review}, journal={RHEUMATOLOGY INTERNATIONAL}, year=2020, pages={169-173} }